PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge CB2 0AW, UK; Department of Medicine, University of Cambridge, Addenbrooke\'s Hospital, Cambridge CB2 0QQ, UK.\', \'Department of Medicine, University of Cambridge, Addenbrooke\'s Hospital, Cambridge CB2 0QQ, UK.\', \'MRC Biostatistics Unit, University of Cambridge, Cambridge Biomedical Campus, Cambridge CB2 0SR, UK.\', \'Cancer Research UK - Cambridge Institute, Robinson Way, Cambridge, CB2 0RE, UK; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Cambridge, UK.\', \'Department of Haematology, Wellcome & MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge CB2 0AW, UK.\', \'Department of Clinical Biochemistry and Immunology, Addenbrooke\'s Hospital, Cambridge CB2 0QQ, UK.\', \'Cambridge Clinical Research Centre, NIHR Clinical Research Facility, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke\'s Hospital, Cambridge CB2 0QQ, UK.\', \'Division of Virology, Department of Pathology, University of Cambridge, Addenbrooke\'s Hospital, Cambridge CB2 0QQ, UK.\', \'Department of Haematology, University of Cambridge, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK; NIHR BioResource, Cambridge University Hospitals NHS Foundation, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK.\', \'Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge CB2 0AW, UK; Department of Medicine, University of Cambridge, Addenbrooke\'s Hospital, Cambridge CB2 0QQ, UK; NHS Blood and Transplant, Cambridge, UK.\', \'The Australian National Phenome Centre, Centre for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Murdoch, Western Australia WA 6150, Australia.\', \'Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge CB2 0AW, UK; Department of Medicine, University of Cambridge, Addenbrooke\'s Hospital, Cambridge CB2 0QQ, UK; MRC Toxicology Unit, School of Biological Sciences, University of Cambridge, Cambridge CB2 1QR, UK.\', \'R&D Department, Hycult Biotech, 5405 PD Uden, the Netherlands.\', \'Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge CB2 0AW, UK.\', \'Department of Medicine, University of Cambridge, Addenbrooke\'s Hospital, Cambridge CB2 0QQ, UK; Heart and Lung Research Institute, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK; Royal Papworth Hospital NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK.\', \'Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge CB2 0AW, UK; Department of Medicine, University of Cambridge, Addenbrooke\'s Hospital, Cambridge CB2 0QQ, UK; Department of Biomedicine, University and University Hospital Basel, 4031 Basel, Switzerland; Botnar Research Centre for Child Health (BRCCH) University Basel & ETH Zurich, 4058 Basel, Switzerland.\', \'Department of Medicine, University of Cambridge, Addenbrooke\'s Hospital, Cambridge CB2 0QQ, UK; NIHR BioResource, Cambridge University Hospitals NHS Foundation, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK.\', \'Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge CB2 0AW, UK; Department of Medicine, University of Cambridge, Addenbrooke\'s Hospital, Cambridge CB2 0QQ, UK. Electronic address: pal34@cam.ac.uk.\', \'Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge CB2 0AW, UK; Department of Medicine, University of Cambridge, Addenbrooke\'s Hospital, Cambridge CB2 0QQ, UK. Electronic address: kgcs2@cam.ac.uk.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1074-7613(21)00216-810.1016/j.immuni.2021.05.010
?:hasPublicationType
?:journal
  • Immunity
is ?:pmid of
?:pmid
?:pmid
  • 34051148
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 13.393
?:rankingScore_hIndex
  • 342
is ?:relation_isRelatedTo_publication of
?:title
  • Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all